Effects of somatostatin analogues on human gastrointestinal motility.
Camilleri
M
M
Mayo Foundation, Mayo Clinic, Rochester, Minn 55905, USA.
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000494:pharmacology*; D003967:Diarrhea / Q000139:chemically induced / Q000209:etiology; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006727:Hormone Antagonists / Q000494:pharmacology*; D006801:Humans; D007082:Ileum / Q000187:drug effects; D008303:Malignant Carcinoid Syndrome / Q000150:complications / Q000503:physiopathology; D016065:Myoelectric Complex, Migrating / Q000187:drug effects; D015282:Octreotide / Q000008:administration & dosage / Q000494:pharmacology*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000494:pharmacology*
D018931:Antineoplastic Agents, Hormonal; D006727:Hormone Antagonists; D013004:Somatostatin; D015282:Octreotide